Guidance

COVID-19 vaccination: blood clotting information for healthcare professionals

Information for healthcare professionals on blood clotting following COVID-19 vaccination.

Applies to England

Documents

Details

Information for healthcare professionals on blood clotting following coronavirus (COVID-19) vaccination.

This publication is subject to extensive and regular revisions and we recommend linking to the latest version to ensure that you are giving the most up-to-date clinical advice and guidance.

Updates to this page

Published 7 April 2021
Last updated 14 February 2022 show all updates
  1. Updated to include information on the risk of relapse of thrombosis and thrombocytopenia symptoms and risk of new or relapse of immune thrombocytopenic purpura following COVID-19 vaccinations.

  2. Added print version.

  3. Updated guidance document.

  4. Updated to include: antiphospholipid syndrome, interchangeability of COVID-19 vaccines, samples required for whole genome sequencing and the latest MHRA data.

  5. Updated information for healthcare professionals on blood clotting following COVID-19 vaccination.

  6. Updated sections: 13, 14, 16, 17, 19, 21 and 22.

  7. Added print version.

  8. First published.

Sign up for emails or print this page